Stay updated on Ponatinib for Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ponatinib for Medullary Thyroid Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The record now presents details for the ponatinib study in advanced or metastatic medullary thyroid cancer, including its design, participant criteria, and outcome measures. It indicates the study was withdrawn by the sponsor and had actual enrollment of zero.
    Difference
    42%
    Check dated 2026-11-09T13:58:27.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov site revision changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T16:12:53.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A sitewide notice announces NIH website updates and explains that some content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-26T15:22:06.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2 while the study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T14:52:20.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T15:54:00.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content with an access-denied message. This indicates an accessibility issue rather than a substantive content update, leaving the page in an error state.
    Difference
    17%
    Check dated 2026-09-21T22:13:22.000Z thumbnail image

Stay in the know with updates to Ponatinib for Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.